
GC15173
Palbociclib
Also listed as PD 0332991 (Palbociclib)
PD 0332991 (Palbociclib) (PD 0332991) is an orally active selective CDK4 and CDK6 inhibitor with IC50 values of 11 and 16 nM, respectively· PD 0332991 (Palbociclib) has potent anti-proliferative activity and induces cell cycle arrest in cancer cells, which can be used in the research of HR-positive and HER2-negative breast cancer and hepatocellular carcinoma
ChemicalCAS571190-30-2MW447.53FormulaC24H29N7O2
- CAS number
- 571190-30-2
- Molecular weight
- 447.53
- Formula
- C24H29N7O2
- Solubility
- 4·5mg/mL in DMSO(ultrasonic and warming and heat to 60°C)
- InChIKey
- AHJRHEGDXFFMBM-UHFFFAOYSA-N
- Catalogue number
- GC15173
- Brand
- GLPBIO
Computed properties PubChem CID 5330286 · XLogP 1.8 · TPSA 103 Ų · H-bond donors 2
- XLogP
- 1.8
- TPSA
- 103 Ų
- H-bond donors
- 2
- H-bond acceptors
- 8
- Rotatable bonds
- 5
- Heavy atoms
- 33
SMILES CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C
Computed descriptors from PubChem (CID 5330286), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il